Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Lupin share price gained in the early trade on July 2 on the back of USFDA approval for Loteprednol Etabonate Ophthalmic Gel. At 09:20am, Lupin was quoting at Rs 1,969.70, up Rs 8.40, or 0.43 ...

advertisement 07-03-2025 TECH ‘There is nothing that Aquaphor will not fix’: The internet is in love with this no-frills skin ointment ...

According to IQVIA MAT data for May 2025, Loteprednol Etabonate Ophthalmic Gel, 0.38% (Reference Listed Drug: Lotemax (R) SM) had estimated annual sales of $29 million in the U.S.

Lupin today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New ...

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

Learn about glaucoma symptoms and cataracts, as well as laser eye surgery and optic nerve regeneration. Read the latest medical research on diagnosis and new treatment options.